Earnings Feed
Sign Up
Home/Filings/4/0001181431-07-006902
4//SEC Filing

ICOS CORP 4

Accession 0001181431-07-006902

CIK 0000874294operating
View on SEC.govCompany Profile

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 5:35 PM ET

Size

20.5 KB

Accession

0001181431-07-006902

Insider Transaction Report

Form 4
Period: 2007-01-29
ICOS CORPICOS
FERGUSON JAMES L
Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-01-29$26.63/sh−20,339$541,526→ 0 total
    Exercise: $7.38From: 1997-05-07Exp: 2007-05-07→ Common Stock (20,339 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-01-29$9.47/sh−21,810$206,541→ 0 total
    Exercise: $24.53From: 2002-05-17Exp: 2012-05-17→ Common Stock (21,810 underlying)
  • Disposition to Issuer

    Common Stock

    2007-01-29$34.00/sh−23,535$800,190→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-01-29$2.89/sh−12,000$34,680→ 0 total
    Exercise: $31.11From: 2004-05-14Exp: 2014-05-14→ Common Stock (12,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-01-29$8.45/sh−20,939$176,935→ 0 total
    Exercise: $25.55From: 2003-05-02Exp: 2013-05-02→ Common Stock (20,939 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-01-29$19.63/sh−9,788$192,090→ 0 total
    Exercise: $14.38From: 1998-05-06Exp: 2008-05-06→ Common Stock (9,788 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-01-29$14.75/sh−1,342$19,795→ 0 total
    Exercise: $19.25From: 1998-06-05Exp: 2008-05-06→ Common Stock (1,342 underlying)
Footnotes (3)
  • [F1]Disposed of pursuant to the Merger Agreement under which Eli Lilly and Company ("Eli Lilly") acquired the Issuer ("Merger") and which provides for the cancellation of shares of common stock of the Issuer in exchange for $34.00 per share (the "Merger Consideration). Includes 7,000 shares underlying unvested restricted stock unit awards.
  • [F2]All options were cancelled pursuant to the Merger Agreement in exchange for cash consideration equal to the Merger Consideration less the exercise price per share.
  • [F3]Vests in two equal amounts as of each of the next two annual stockholders' meetings of the Issuer following the grant date indicated, assuming continued service on the Board of Directors.

Documents

1 file

Issuer

ICOS CORP

CIK 0000874294

→
Entity typeoperating
IncorporatedWA

Related Parties

1
  • filerCIK 0000874294

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:35 PM ET
Size
20.5 KB
View on SEC.gov